Impact of Personalized and Remote Support Centered on Exercise and Physical Activity for Breast Cancer Patients

Other illness

• Relapse of invasive breast cancer (loco-regional relapse, contralateral relapse)
• Metastatic cancer;

Other

• Inability to exercise because of a severe handicap or vulnerability. These contraindications are left to the discretion of the healthcare professional assessing capacity (ex : severe malnutrition, pregnancy …);
• Expressed preference for one arm;
• Inability to comply with follow-up (4 and 12 months) of the trial (geographical, social, medical or psychological reasons);
• Person under guardianship or curatorship.

• Patient ≥18;
• Diagnosis of invasive non-metastatic breast cancer;
• 5 months (+/- 3 months) after the end of the treatment by surgery and/or radiotherapy and/or chemotherapy and/or other "short-term" systemic treatment : immunotherapy, PARP inhibitor, trastuzumab or TDM1 ; the continuation of hormonotherapy (more or less associated with an anti-CDK4/6), trastuzumab or TDM1 is possible during the study period;
• SF-36 filled in completely
• Medical certificate for sports practice delivered by a healthcare professional or oncologist. Neither the previous sports practice, nor the motivation for the proposed program is necessary to participate in the program.
• Agreement for follow-ups during the study period lasting 12 months;
• Ability to understand, read and write French;
• Patient covered by the French "Social Security" regime;
• Signed informed consent for the participation in the study, including the randomization with a 50%/50% chance of being allocated to one or the other group.